Beta-sitosterol mitigates type 2 diabetes-induced cognitive deficits: a behavioral and molecular investigation in Swiss albino mice
- 1Department of Pharmacology, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001 Punjab, India.
- 2Department of Pharmacology, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001 Punjab, India; Department of Pharmacology, School of Pharmacy & Technology Management, SVKM's NMIMS University, Shirpur Campus, Shirpur, India.
- 0Department of Pharmacology, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001 Punjab, India.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study shows that β-sitosterol (BST) can protect against cognitive impairment caused by type 2 diabetes mellitus (T2DM). BST treatment improved memory and brain health in diabetic mice, highlighting its neuroprotective potential.
Area Of Science
- Neuroscience
- Endocrinology
- Pharmacology
Background
- Type 2 diabetes mellitus (T2DM) is linked to long-term cognitive impairment.
- Understanding the neuroprotective mechanisms against diabetes-induced cognitive deficits is crucial.
Purpose Of The Study
- To investigate the neuroprotective effects of β-sitosterol (BST) against cognitive impairment in a mouse model of T2DM.
- To evaluate the impact of BST on cognitive function, metabolic parameters, and neuroinflammation.
Main Methods
- T2DM was induced in mice using a cafeteria diet and streptozotocin (STZ).
- Cognitive function was assessed using behavioral tests (radial arm maze, nest building, novel object recognition).
- Biochemical, molecular, and histopathological analyses were performed on brain tissue and blood samples.
Main Results
- BST treatment (10 and 20 mg/kg) significantly improved spatial learning, memory, and recognition in T2DM mice.
- BST ameliorated hyperglycemia, dyslipidemia, oxidative stress (restored GSH, CAT; reduced MDA), and neuroinflammation (increased IL-10, reduced IL-1β, TNF-α).
- BST treatment also modulated key signaling pathways, increasing Akt and decreasing Gsk-3β phosphorylation, suggesting neuroprotection.
Conclusions
- β-sitosterol demonstrates significant neuroprotective effects against T2DM-induced cognitive deficits.
- The cognitive benefits of BST are likely mediated by its antioxidant, anti-inflammatory, and metabolic regulatory properties.
- BST holds potential as a therapeutic agent for managing cognitive decline associated with type 2 diabetes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

